Manufacturers of drugs and other medical products can participate at different stages of report preparation in IQWiG's assessments:
Submission of comments on the procedure and preliminary results: The Institute offers all interested parties the opportunity to comment in a formal Comments procedure (hearing) on preliminary report plans, amendments to report plans and preliminary reports.
Provision of additional study data: IQWiG would like to carry out the assessment of drugs based on the most complete set of data possible and therefore requests that manufacturers provide as yet unpublished studies. In collaboration with the German Association of Research-based Pharmaceutical Companies (VFA), the Institute has drawn up a sample contract for the transfer of these data.
